FK506-binding protein 51 acted as an intermediate bridge molecule to bind Akt and PHLPP and accelerated PHLPP dephosphorylation of p-Akt (S473), thereby increasing the sensitivity of pancreatic cancer cells to chemotherapy drugs [26, 27]. Here, AKT1 is linked to pancreatic neoplasm.